Lowering Costs by Improving Biosimilar Uptake Act
Summary
Lowering Costs by Improving Biosimilar Uptake Act This bill allows for the omission of certain information relating to the strength of a product in a biosimilar application, as determined by the Food and Drug Administration.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2022
Committee Review
Floor Vote
President
Introduced Mar 9, 2022
Last action Mar 10, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Mar 10, 2022
Committee
Referred to the Subcommittee on Health.
lower
Mar 9, 2022
Committee
Referred to the House Committee on Energy and Commerce.
lower
Mar 9, 2022
Introduced
Introduced in House
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Kurt Schrader
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 7047
Scope: US
Hi! I can help you understand HR 7047. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline